Cullinan Associates Inc. Cuts Position in Morgan Stanley (NYSE:MS)

Cullinan Associates Inc. lessened its holdings in Morgan Stanley (NYSE:MSFree Report) by 5.5% during the first quarter, Holdings Channel.com reports. The institutional investor owned 37,052 shares of the financial services provider’s stock after selling 2,141 shares during the quarter. Cullinan Associates Inc.’s holdings in Morgan Stanley were worth $4,323,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds and other institutional investors have also recently modified their holdings of the business. Minot DeBlois Advisors LLC bought a new stake in shares of Morgan Stanley in the 4th quarter worth approximately $25,000. IAG Wealth Partners LLC bought a new stake in shares of Morgan Stanley in the 4th quarter worth approximately $28,000. Garde Capital Inc. bought a new stake in shares of Morgan Stanley in the 1st quarter worth approximately $30,000. Curio Wealth LLC bought a new stake in shares of Morgan Stanley in the 4th quarter worth approximately $31,000. Finally, Ancora Advisors LLC raised its holdings in shares of Morgan Stanley by 104.7% in the 4th quarter. Ancora Advisors LLC now owns 264 shares of the financial services provider’s stock worth $33,000 after purchasing an additional 135 shares during the period. Hedge funds and other institutional investors own 84.19% of the company’s stock.

Insider Buying and Selling

In related news, insider Eric F. Grossman sold 10,068 shares of the company’s stock in a transaction on Tuesday, April 15th. The shares were sold at an average price of $111.65, for a total value of $1,124,092.20. Following the completion of the transaction, the insider now directly owns 199,274 shares in the company, valued at approximately $22,248,942.10. The trade was a 4.81% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Andrew M. Saperstein sold 40,000 shares of the company’s stock in a transaction on Friday, May 2nd. The stock was sold at an average price of $120.00, for a total transaction of $4,800,000.00. Following the completion of the transaction, the insider now owns 335,765 shares of the company’s stock, valued at $40,291,800. This trade represents a 10.64% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 50,868 shares of company stock worth $6,019,548. Corporate insiders own 0.19% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities research analysts recently commented on MS shares. JPMorgan Chase & Co. lowered their price target on shares of Morgan Stanley from $125.00 to $122.00 and set a “neutral” rating on the stock in a report on Monday, April 14th. The Goldman Sachs Group boosted their target price on shares of Morgan Stanley from $121.00 to $136.00 and gave the company a “neutral” rating in a report on Tuesday, June 10th. Evercore ISI lowered their target price on shares of Morgan Stanley from $150.00 to $138.00 and set an “outperform” rating on the stock in a report on Tuesday, April 1st. Erste Group Bank raised shares of Morgan Stanley from a “hold” rating to a “strong-buy” rating in a report on Saturday, May 24th. Finally, JMP Securities reissued a “market perform” rating on shares of Morgan Stanley in a report on Monday, April 14th. Eleven analysts have rated the stock with a hold rating, five have assigned a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Hold” and an average target price of $133.62.

Get Our Latest Stock Report on MS

Morgan Stanley Trading Up 0.0%

Morgan Stanley stock opened at $132.56 on Friday. The stock has a market cap of $212.67 billion, a P/E ratio of 15.56, a PEG ratio of 1.21 and a beta of 1.29. Morgan Stanley has a fifty-two week low of $90.94 and a fifty-two week high of $142.03. The firm’s fifty day moving average price is $123.65 and its 200-day moving average price is $125.21. The company has a debt-to-equity ratio of 3.11, a quick ratio of 0.78 and a current ratio of 0.78.

Morgan Stanley (NYSE:MSGet Free Report) last released its quarterly earnings results on Friday, April 11th. The financial services provider reported $2.60 earnings per share for the quarter, topping the consensus estimate of $2.21 by $0.39. The firm had revenue of $17.74 billion for the quarter, compared to analysts’ expectations of $16.81 billion. Morgan Stanley had a net margin of 12.98% and a return on equity of 14.98%. The business’s quarterly revenue was up 17.2% on a year-over-year basis. During the same quarter in the prior year, the firm posted $2.02 earnings per share. Equities research analysts forecast that Morgan Stanley will post 8.56 earnings per share for the current fiscal year.

Morgan Stanley Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Thursday, May 15th. Investors of record on Wednesday, April 30th were given a $0.925 dividend. The ex-dividend date was Wednesday, April 30th. This represents a $3.70 annualized dividend and a yield of 2.79%. Morgan Stanley’s dividend payout ratio (DPR) is presently 43.43%.

Morgan Stanley Company Profile

(Free Report)

Morgan Stanley, a financial holding company, provides various financial products and services to corporations, governments, financial institutions, and individuals in the Americas, Europe, the Middle East, Africa, and Asia. It operates through Institutional Securities, Wealth Management, and Investment Management segments.

Recommended Stories

Want to see what other hedge funds are holding MS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Morgan Stanley (NYSE:MSFree Report).

Institutional Ownership by Quarter for Morgan Stanley (NYSE:MS)

Receive News & Ratings for Morgan Stanley Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Morgan Stanley and related companies with MarketBeat.com's FREE daily email newsletter.